CVR: 45009092
Secondary names: C2N Diagnostics Denmark ApS, C2N EU ApS
DKK -129,956
Gross profit
Net result: DKK -140,078
C2N Global, Inc
CVR · view ownership and management
Director registered: Dr. Joel B. Braunstein
CVR · 09/08/2024
View the full event history
C2N Diagnostics EU ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2024. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Dr. Joel B. Braunstein. The company is owned by C2N Global, Inc. In 2025, the company reported a gross profit of DKK -129,956 and a net result of DKK -140,078. Equity in the 2025 report amounted to DKK -202,154.
Selskabets formål er at engagere sig i følgende forretningsaktiviteter: 1) Forskning og udvikling samt fremstilling af diagnostiske og terapeutiske produkter; 2) Engroshandel og detailhandel med diagnostiske og terapeutiske produkter; 3) Import, eksport, markedsføring og eftersalgsservice af diagnostiske og terapeutiske produkter; og hermed beslægtet virksomhed efter direktions skøn.
Source: annual reports filed with the Danish Business Authority.
Compared to 1.041 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreC2N Diagnostics EU ApS was founded on 9 August 2024.
C2N Diagnostics EU ApS is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (industry code 721000).
C2N Diagnostics EU ApS is owned by C2N Global, Inc.
In 2025, C2N Diagnostics EU ApS reported a gross profit of DKK -129,956.
The management of C2N Diagnostics EU ApS consists of Dr. Joel B. Braunstein.
C2N Diagnostics EU ApS is located at c/o DLA Piper Advokatpartnerselskab, Oslo Plads 2, 2100 København Ø.
Claim this page to add your logo and social links. Free to get started.
C2N Diagnostics EU ApS has published its annual report for 2025. Gross profit came to DKK -129,956, and the net result was DKK -140,078.
C2N Diagnostics EU ApS has published its interim report for the period August 9, 2024 – December 31, 2024.
As of August 9, 2024, Dr. Joel B. Braunstein is registered as director of C2N Diagnostics EU ApS.
As of August 9, 2024, is registered as an owner of C2N Diagnostics EU ApS with an ownership share of 100%.
C2N Diagnostics EU ApS was founded on August 9, 2024.
Companies in the same industry and area
CVR 29418888
CVR 29769796
CVR 34688605
CVR 34892970
CVR 35047565
